Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure

NCT02431221 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Lack of efficacy in a preceding study.

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG: Perhexiline
DRUG: Placebo

Sponsor

Heart Metabolics Limited